Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
25%
Ph phase_1
3
75%

Phase Distribution

3

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 3Large-scale testing
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 13 (75.0%)
Phase 31 (25.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completedphase_1

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

NCT02243319
completedphase_3

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

NCT02667938
completedphase_1

PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

NCT02715401
completedphase_1

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

NCT02712411

Clinical Trials (4)

Showing 4 of 4 trials
NCT02243319Phase 1

Investigating the Pharmacokinetic Drug Interactions Between HGP1201 and HGP0904

Completed
NCT02667938Phase 3

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules

Completed
NCT02715401Phase 1

PK and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 Under Fed Condition in Healthy Male Volunteers

Completed
NCT02712411Phase 1

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4